Albumin Administration Guidelines

Evidence-Based Indications for Albumin Administration

The American Association for the Study of Liver Diseases recommends administering albumin in patients with cirrhosis undergoing large-volume paracentesis (>5L) at 6-8 g per liter of ascites removed 1, 2
The American Association for the Study of Liver Diseases suggests giving 1.5 g/kg on day 1 and 1.0 g/kg on day 3, in addition to antibiotics, for patients with spontaneous bacterial peritonitis (SBP) 1, 2
The European Association for the Study of the Liver recommends administering 20-40 g/day of albumin during terlipressin treatment for hepatorenal syndrome 3
Administering albumin at 1 g/kg before initiating vasoconstrictor treatment is recommended for patients with hepatorenal syndrome 3

The American College of Chest Physicians suggests that albumin is NOT indicated for first-line volume replacement or to increase serum albumin levels in general critically ill adults 5
The American College of Chest Physicians recommends NOT using albumin for routine treatment of hypoalbuminemia 6, 5
Albumin does NOT reduce AKI or mortality in cirrhosis patients with non-SBP infections, and is associated with MORE pulmonary edema 1

The American Association for the Study of Liver Diseases notes that doses exceeding 87.5 g (>4×100 mL of 20% albumin) are potentially associated with worse outcomes due to fluid overload 4
Pulmonary edema has been reported as an adverse event, particularly with rapid administration of albumin 1, 4
Euvolemic patients should be limited to 2 mL/min (≈120 mL/hour for 25% albumin) when administering albumin 4
Never use serum albumin levels alone to guide infusion rate—volume status is the critical determinant 4
Monitor continuously for fluid overload, especially when total doses exceed 87.5 g 4